CURES Enrollment Extended to July 1, 2016

The CURES enrollment deadline for providers has officially been pushed back from January 1, 2016 to July 1, 2016

The change comes after Governor Brown signed AB 679. The bill was amended late in the legislative session due to concern that the most recent Controlled Substance Utilization Review and Evaluation System (CURES) update has fallen behind schedule. The CURES 2.0 was planned to be in use by July 1 of this year, yet the system is still not fully operational. The delay will give the Department of Justice (DOJ) time to finalize CURES 2.0 and for providers to enroll.

CPMA supported AB 679 due to concern that the CURES 2.0 rollout was not meeting deadlines, and had the potential to create unnecessary confusion among members, and exacerbating frustrations that many have had with the system already.

Now, all providers who are authorized to prescribe, order, administer, furnish or dispense controlled substances must register for CURES by July 1, 2016. Dispensed controlled substance prescriptions can be recorded in CURES, which allows prescribers to look up a patient's controlled substance current usage and past history.

The CURES requirement was established as part of a bill enacted in 2014 (SB 809 DeSaulneir). This legislation required the DOJ, in conjunction with the Department of Consumer Affairs (DCA) and licensing boards like the Board of Podiatric Medicine, to develop a streamlined application and approval process to provide access to the CURES database, also known as the California Prescription Drug Monitoring Program (PDMP), for licensed health care practitioners and pharmacists.

CPMA will continue to monitor the situation, communicate with DOJ and update members on progress. Though burdensome, it is recommended that doctors who need access to CURES not wait for streamlined registration, but begin the process for registration as soon as possible.  If prescribing providers have any questions they can email cures@doj.ca.gov.